![]() |
An FDA/Tobacco bill similar to H.R. 1256, as recently passed by the House will be marked up by the Senate HELP Committee in mid-May, then introduced to the Senate floor late May or Early June. If the text of this bill accurately reflected the summary used to attract endorsements and congressional sponsors, we, too, would be enthusiastically endorsing this bill as proposed. Unfortunately, as a result of our careful reading of the entire bill and multiple attempts to seek the opinion of Representative Waxman's Office, the Campaign for Tobacco Free Kids (CTFK) and other organizations endorsing the bill -- we have reluctantly reached the conclusions that this bill, if passed in its current form, would do more harm than good in terms of future tobacco-related illness and death. I ignores the plight of current adult American smokers. It gives the image, but not the substance of effective federal regulatory authority. For detail and justification for these seemingly radical views, please see the May 5 Senate Amendments and the other documents listed below. (this note prepared by Dr. Joel NItzkin, Chair of the Tobacco Control Task Force of the American Association of Public Health Physicians, May 5, 2009.
Petition to FDA:
The E-Cigarette as Tobacco Product (rather than drug/device combination)
AAPHP White Paper:
The E-Cigarette in the Context of Overall Tobacco Control
Lessons Learned, Tobacco Control, 2008/09 posted 9/30/20009
Citi (Wall Street) analysis of projected impact of FDA regulation on cigarette sales by major cigarette company June 21, 2009 (With Permisson)
FDA: What Does it Mean for Investors? June 18.2009 (With Permission of UBS)
Senate Amendments Recommended for FDA/Tobacco Bill (based on H.R.1256) May 5, 2009
Projections of Alternative Approaches to Federal Legislation re Tobacco Control March 3, 2009
Fax to House Energy and Commerce Committee March 3, 2009
Promoting Snus, Response to Zhu et al, February 6, 2009
The abstract and our response are accessible from TC at http://tobaccocontrol.bmj.com/cgi/eletters/tc.2008.028209v1
AAPHP TCTF Challenge to FDA/Tobacco Bill January 12, 2009
Nitzkin Letter to Editor, NEJM, Published 11/6/08,and Response by Brandt
Resolution and White Paper on Harm Reduction - (October 26, 2008)
HR1108/S625 The Myth of the Safe Cigarette (with technical references) 8/19/08
Full Text of of FDA/Tobacco Bill S.625/H.R. 1108 as of May 3, 2008
AAPHP Full Analysis of S.625/H.R. 1108 (July 12, 2007)
Tobacco harm reduction: an alternative cessation strategy for inveterate smokers - Rodu & Godshall (December 21. 2007
Wall Street Analyses of Impact of FDA/Tobacco Bill March 14, 2000
Morgan Stanley Analysis of Impact of FDA/Tobacco Bill February 15, 2000
"Koop-Kessler Recommendations for Federal Tobacco Policy (December 18, 2003)
For further information please contact Dr. Joel Nitzkin, Chair, AAPHP Tobacco Control Task Force, at jln-md@mindspring.com
Last modified: December 22, 2009